Edition:
United States

Molecular Medicine SpA (MLMD.MI)

MLMD.MI on Milan Stock Exchange

0.30EUR
10:29am EDT
Change (% chg)

€-0.01 (-2.60%)
Prev Close
€0.31
Open
€0.31
Day's High
€0.31
Day's Low
€0.29
Volume
1,465,035
Avg. Vol
1,737,095
52-wk High
€0.60
52-wk Low
€0.29

Chart for

About

Molecular Medicine SpA (MolMed) is an Italy-based company engaged in the medical biotechnology sector. The Company is active in the research, development and clinical validation of therapies for the treatment of cancer. The Company’s activities include identification and development of bio-pharmaceuticals reducing the tumor mass... (more)
No analyst recommendations are available for .

Overall

Beta: 0.78
Market Cap(Mil.): €155.26
Shares Outstanding(Mil.): 463.45
Dividend: --
Yield (%): --

Financials

  MLMD.MI Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.01 -- --
ROI: -19.96 1.96 12.83
ROE: -25.02 1.12 14.95

BRIEF-Molmed SpA Signs Master Service Agreement With Boston Children's Hospital For Supply Of Lentiviral Vectors

* SIGNS 5 YEAR MASTER SERVICE AGREEMENT WITH BOSTON CHILDREN'S HOSPITAL FOR SUPPLY OF LENTIVIRAL VECTORS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

May 04 2018

Earnings vs. Estimates